These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3907315

  • 1. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
    Groves BM, Rubin LJ, Frosolono MF, Cato AE, Reeves JT.
    Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
    Adnot S, Defouilloy C, Brun-Buisson C, Abrouk F, Piquet J, Lemaire F.
    Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
    [Abstract] [Full Text] [Related]

  • 3. Oral hydralazine therapy for primary pulmonary hypertension.
    Rubin LJ, Peter RH.
    N Engl J Med; 1980 Jan 10; 302(2):69-73. PubMed ID: 7350435
    [Abstract] [Full Text] [Related]

  • 4. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.
    Nootens M, Schrader B, Kaufmann E, Vestal R, Long W, Rich S.
    Chest; 1995 Jan 10; 107(1):54-7. PubMed ID: 7813311
    [Abstract] [Full Text] [Related]

  • 5. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE, Keene BW, McGuirk SM, Sato T.
    Am J Vet Res; 1994 Feb 10; 55(2):262-9. PubMed ID: 8172418
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
    Fisher J, Borer JS, Moses JW, Goldberg HL, Niarchos AP, Whitman HH, Mermelstein M.
    Am J Cardiol; 1984 Sep 01; 54(6):646-50. PubMed ID: 6475787
    [Abstract] [Full Text] [Related]

  • 7. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C, Brenot F, Blétry O, Simmonneau G, Duroux P.
    Rev Mal Respir; 1990 Sep 01; 7(3):249-54. PubMed ID: 2114030
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
    Moskowitz RM, Cohn JN.
    Clin Pharmacol Ther; 1980 Jun 01; 27(6):773-8. PubMed ID: 7379444
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.
    Barst RJ.
    Chest; 1986 Apr 01; 89(4):497-503. PubMed ID: 2869919
    [Abstract] [Full Text] [Related]

  • 10. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N, Lundin S, Ricksten SE.
    J Heart Lung Transplant; 1995 Apr 01; 14(3):436-43. PubMed ID: 7654728
    [Abstract] [Full Text] [Related]

  • 11. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV, Genthner DE, Panella MM, Rich S.
    N Engl J Med; 1998 Jan 29; 338(5):273-7. PubMed ID: 9445406
    [Abstract] [Full Text] [Related]

  • 12. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.
    McGoon MD, Seward JB, Vlietstra RE, Choo MH, Moyer TP, Reeder GS.
    Br Heart J; 1983 Dec 29; 50(6):579-85. PubMed ID: 6652000
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
    Cerdá E, Esteban A, de la Cal MA, Fernández A, García A.
    Crit Care Med; 1985 Apr 29; 13(4):221-3. PubMed ID: 3979067
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI, Silke B, Forsyth DR, Verma SP, Hussain M, Taylor SH.
    Am J Cardiol; 1983 Nov 01; 52(8):1036-40. PubMed ID: 6637819
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC, McLean R, Rosenthal MH, Pearl RG.
    Crit Care Med; 1991 Jan 01; 19(1):60-7. PubMed ID: 1986891
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
    Rubin LJ, Peter RH.
    Am J Cardiol; 1981 Jan 01; 47(1):116-22. PubMed ID: 7457397
    [Abstract] [Full Text] [Related]

  • 17. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
    Rich S, Ganz R, Levy PS.
    Am J Cardiol; 1983 Nov 01; 52(8):1104-7. PubMed ID: 6637831
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E, Seoane M, Verdejo J, Gomez A, Sandoval J, Barrios R, Martinez W.
    Chest; 1985 May 01; 87(5):564-73. PubMed ID: 3987368
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
    Kuzniar J, Skret A, Piela A, Szmigiel Z, Zaczek T.
    Obstet Gynecol; 1985 Oct 01; 66(4):453-8. PubMed ID: 4047535
    [Abstract] [Full Text] [Related]

  • 20. Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol.
    Rossi R, Coppi F, Sgura F, Monopoli D, Boriani G.
    Pulm Pharmacol Ther; 2018 Apr 01; 49():147-151. PubMed ID: 28642014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.